STOCKWATCH
·
Pharmaceuticals
Joint Venture12 Mar 2026, 10:32 pm

Natural Biogenex and Fermbox Bio Enter Strategic Framework and Manufacturing Agreements

AI Summary

Natural Biogenex Private Limited, a subsidiary of Natural Capsules Limited, has executed definitive Framework and Contract Manufacturing Agreements with Fermbox Bio Private Limited to jointly advance fermentation-based Contract Development and Manufacturing (CDMO) services. The partnership positions the Company to serve global biotechnology and biopharma clients with integrated, GMP-compliant manufacturing capacity and enhanced process efficiency. The global biotech and biopharma CDMO market continues to present strong growth opportunities, driven by rising demand, increasing outsourcing, and more complex biomanufacturing requirements. India is strategically placed to capture a meaningful share of this opportunity, tapping into its bio- manufacturing strength and a growing CDMO sector.

Key Highlights

  • Natural Biogenex and Fermbox Bio have entered into strategic Framework and Manufacturing Agreements.
  • The partnership aims to advance fermentation-based Contract Development and Manufacturing (CDMO) services.
  • The collaboration will serve global biotechnology and biopharma clients with integrated, GMP-compliant manufacturing capacity and enhanced process efficiency.
  • India's CDMO sector is growing, and this partnership aims to tap into this opportunity.
  • The global biotech and biopharma CDMO market is presenting strong growth opportunities.
NATCAPSUQ
Pharmaceuticals
NATURAL CAPSULES LTD.

Price Impact